IPG Investment Advisors’s Gilead Sciences GILD Stock Holding History

IPG Investment Advisors’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-1,670	Closed	-$233K	–	281
2026 Q1	$233K	Buy	+1,670	New	+$234K	0.04%	204
2025 Q1	–	Sell	-2,350	Closed	-$217K	–	179
2024 Q4	$217K	Buy	+2,350	New	+$212K	0.05%	156
2020 Q2	–	Sell	-2,990	Closed	-$224K	–	139
2020 Q1	$224K	Buy	+2,990	New	+$207K	0.09%	104
2019 Q2	–	Sell	-3,400	Closed	-$221K	–	155
2019 Q1	$221K	Hold	3,400	–	–	0.08%	131
2018 Q4	$213K	Hold	3,400	–	–	0.08%	126
2018 Q3	$263K	Hold	3,400	–	–	0.08%	136
2018 Q2	$241K	Buy	+3,400	New	+$240K	0.08%	133
2017 Q3	–	Sell	-17,509	Closed	-$1.24M	–	148
2017 Q2	$1.24M	Sell	17,509 -264	-1%	-$17.6K	0.5%	35
2017 Q1	$1.21M	Buy	17,773 +9,727	+121%	+$684K	0.54%	33
2016 Q4	$576K	Hold	8,046	–	–	0.23%	65
2016 Q3	$637K	Buy	+8,046	New	+$654K	0.27%	55
2015 Q3	–	Sell	-6,779	Closed	-$794K	–	133
2015 Q2	$794K	Sell	6,779 -5,500	-45%	-$601K	0.29%	66
2015 Q1	$1.2M	Buy	12,279 +5,250	+75%	+$533K	0.46%	41
2014 Q4	$663K	Buy	+7,029	New	+$727K	0.26%	56

Other funds holding GILD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

IPG Investment Advisors's GILD Position: Q2 2026 in Review

IPG Investment Advisors sold out of Gilead Sciences (GILD) in Q2 2026, closing a stake of 1,670 shares — an estimated $233K sold.

IPG Investment Advisors first reported a position in GILD in Q4 2014 and held it in 14 quarters. The position peaked at $1.24M in Q2 2017. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

IPG Investment Advisors reported no remaining Gilead Sciences position as of Q2 2026 after selling out during the quarter.
IPG Investment Advisors sold 1,670 Gilead Sciences shares in Q2 2026, an estimated $233K.
IPG Investment Advisors first reported a position in Gilead Sciences in Q4 2014 and held it in 14 quarters.
IPG Investment Advisors's Gilead Sciences position peaked at $1.24M in Q2 2017.
2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on IPG Investment Advisors's 13F filing for Q2 2026, filed 12 Aug 2026.